AR049028A1 - Sal solida farmaceuticamente adecuada y que no sublima del enantiomero s de mirtazapina y metodo de fabricacion - Google Patents

Sal solida farmaceuticamente adecuada y que no sublima del enantiomero s de mirtazapina y metodo de fabricacion

Info

Publication number
AR049028A1
AR049028A1 ARP050101549A ARP050101549A AR049028A1 AR 049028 A1 AR049028 A1 AR 049028A1 AR P050101549 A ARP050101549 A AR P050101549A AR P050101549 A ARP050101549 A AR P050101549A AR 049028 A1 AR049028 A1 AR 049028A1
Authority
AR
Argentina
Prior art keywords
mirtazapine
enantiomer
manufacturing
sublimate
solid salt
Prior art date
Application number
ARP050101549A
Other languages
English (en)
Spanish (es)
Inventor
Sytske Hyke Moolenaar
Der Voort Maarschalk Kees Van
Gerardus Johannes Kemperman
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of AR049028A1 publication Critical patent/AR049028A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP050101549A 2004-04-21 2005-04-20 Sal solida farmaceuticamente adecuada y que no sublima del enantiomero s de mirtazapina y metodo de fabricacion AR049028A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP04101664 2004-04-21

Publications (1)

Publication Number Publication Date
AR049028A1 true AR049028A1 (es) 2006-06-21

Family

ID=34928990

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP050101549A AR049028A1 (es) 2004-04-21 2005-04-20 Sal solida farmaceuticamente adecuada y que no sublima del enantiomero s de mirtazapina y metodo de fabricacion

Country Status (31)

Country Link
US (1) US20070111993A1 (enExample)
EP (1) EP1729777B1 (enExample)
JP (2) JP5260959B2 (enExample)
CN (2) CN1942191B (enExample)
AR (1) AR049028A1 (enExample)
AT (1) ATE424210T1 (enExample)
AU (1) AU2005235383B2 (enExample)
BR (1) BRPI0509953A (enExample)
CA (1) CA2561281C (enExample)
CY (1) CY1109018T1 (enExample)
DE (1) DE602005013066D1 (enExample)
DK (1) DK1729777T3 (enExample)
EC (1) ECSP066938A (enExample)
ES (1) ES2321961T3 (enExample)
HR (1) HRP20090190T1 (enExample)
IL (1) IL178201A (enExample)
LV (1) LV13556B (enExample)
MX (1) MXPA06011830A (enExample)
MY (1) MY144899A (enExample)
NO (1) NO20065077L (enExample)
NZ (1) NZ550052A (enExample)
PE (1) PE20060400A1 (enExample)
PL (1) PL1729777T3 (enExample)
PT (1) PT1729777E (enExample)
RS (1) RS50764B (enExample)
RU (1) RU2375362C2 (enExample)
SI (1) SI1729777T1 (enExample)
TW (1) TW200538100A (enExample)
UA (1) UA89773C2 (enExample)
WO (1) WO2005102352A1 (enExample)
ZA (1) ZA200608305B (enExample)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA83666C2 (ru) * 2003-07-10 2008-08-11 Н.В. Органон Способ получения энантиомерно чистого миртазапина
EP1792618A1 (en) * 2005-11-30 2007-06-06 Rainer Freynhagen R-mirtazapine for the treatment of pain
TW200808804A (en) * 2006-05-22 2008-02-16 Organon Nv Mirtazapine for the treatment of neuropathic pain
CN104095824B (zh) * 2013-04-09 2016-08-31 上海信谊万象药业股份有限公司 一种米氮平缓释片及其制备方法
JP6876003B2 (ja) 2015-02-27 2021-05-26 デクラ リミテッド イヌ及びネコにおける、食欲の刺激、体重減少の管理、及び拒食症の処置
CN111053735A (zh) * 2020-02-25 2020-04-24 上海阶平医院管理有限公司 一种治疗失眠的冷敷凝胶

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL189199C (nl) * 1975-04-05 1993-02-01 Akzo Nv Werkwijze ter bereiding van farmaceutische preparaten met werking op het centraal zenuwstelsel op basis van benz(aryl)azepinederivaten, de verkregen gevormde farmaceutische preparaten, alsmede werkwijze ter bereiding van de toe te passen benz(aryl)azepinederivaten.
US4193828A (en) * 1976-07-27 1980-03-18 Fiber Materials, Inc. Method of forming carbon composites
US4515792A (en) * 1982-09-30 1985-05-07 Ciba-Geigy Corporation Tetracyclic heterocycles and antidepressant compositions thereof
IL121076A (en) * 1996-06-19 2000-10-31 Akzo Nobel Nv Pharmaceutical combinations comprising mirtazapine and one or more selective serotonin reuptake inhibitors
EP0813873B1 (en) * 1996-06-19 2002-02-13 Akzo Nobel N.V. Pharmaceutical composition comprising mirtazapine and one or more selective serotonin reuptake inhibitors
ES2212550T3 (es) * 1998-04-02 2004-07-16 Akzo Nobel N.V. Solucion oral liquida que comprende el antidepresor mirtazapina.
WO2001000196A2 (en) * 1999-06-25 2001-01-04 University Of South Florida Mirtazapine for weight gain in wasting diseases
US6281207B1 (en) * 1999-09-15 2001-08-28 Reed Richter Treatment of movement disorders by administration of mirtazapine
WO2001042239A1 (en) * 1999-12-13 2001-06-14 Sumika Fine Chemicals Co., Ltd. Process for the preparation of a pyridinemethanol compound
HK1047547B (en) * 2000-04-05 2003-10-10 Akzo Nobel N.V. Drug combination for the treatment of headache comprising mirtazapine and paracetamol or a non-steroidal anti-inflammatory drug

Also Published As

Publication number Publication date
JP2007533705A (ja) 2007-11-22
BRPI0509953A (pt) 2007-09-25
US20070111993A1 (en) 2007-05-17
AU2005235383A1 (en) 2005-11-03
ECSP066938A (es) 2006-12-20
DK1729777T3 (da) 2009-06-08
PE20060400A1 (es) 2006-05-27
IL178201A0 (en) 2006-12-31
ATE424210T1 (de) 2009-03-15
NZ550052A (en) 2010-02-26
PT1729777E (pt) 2009-04-27
AU2005235383B2 (en) 2010-05-27
SI1729777T1 (sl) 2009-08-31
RU2006140988A (ru) 2008-05-27
EP1729777A1 (en) 2006-12-13
RS50764B (sr) 2010-08-31
CN101824035A (zh) 2010-09-08
CN1942191A (zh) 2007-04-04
EP1729777B1 (en) 2009-03-04
CN1942191B (zh) 2011-02-02
MXPA06011830A (es) 2007-03-23
RU2375362C2 (ru) 2009-12-10
JP2013136626A (ja) 2013-07-11
DE602005013066D1 (de) 2009-04-16
WO2005102352A1 (en) 2005-11-03
UA89773C2 (ru) 2010-03-10
CA2561281C (en) 2013-04-02
MY144899A (en) 2011-11-30
ZA200608305B (en) 2008-08-27
IL178201A (en) 2010-06-30
JP5260959B2 (ja) 2013-08-14
LV13556B (en) 2007-07-20
NO20065077L (no) 2006-11-14
CY1109018T1 (el) 2014-07-02
PL1729777T3 (pl) 2009-07-31
CA2561281A1 (en) 2005-11-03
TW200538100A (en) 2005-12-01
ES2321961T3 (es) 2009-06-15
HRP20090190T1 (en) 2009-05-31

Similar Documents

Publication Publication Date Title
CL2009000903A1 (es) Composiciones farmacéuticas que comprenden un núcleo que contiene una droga débilmente básica seleccionada de derivados de butirofenona, una capa de amortiguador de ph alcalino y un recubrimiento de liberación controlada, método para preparar dichas composiciones y formas de dosificación farmacéutica que las incluyen.
AR054114A1 (es) Composiciones farmaceuticas que comprenden imatinib y un retardador de la liberacion
UY29199A1 (es) Derivados tiazol, composiciones que los contienen, procedimientos de preparación y aplicaciones
NO20081569L (no) Administrasjon av dipeptidylpeptildaseinhibitorer
NO20081592L (no) Dipeptidylpeptidaseinhibitorer for behandling av diabetes
AR061446A1 (es) Utilizacion de la 1,7 -dimetilxantina para la fabricacion de un medicamento psicoanaleptico no ansiogeno destinado al tratamiento de un trastorno neuropsiquiatrico
CL2007001918A1 (es) Compuestos derivados heteroarilos sustituidos; metodo para la preparacion de los compuestos; composicion farmaceutica; y uso para el tratamiento del dolor, depresion, enfermedad de alzheimer e hipertension entre otras.
ECSP056020A (es) Inhibidores del factor inhibidor de la migración de los macrofagos y metodos para su identificacion
NO20093146L (no) Amino-pyridinderivater som S1P1/EDG1-reseptoragonister
AR063538A1 (es) Tratamiento de la enfermedad de parkinson
CU23167A3 (es) Inhibidores de la recaptacion de monoaminas para el tratamiento de trastornos del snc
CL2009001346A1 (es) Compuestos derivados heterociclicos, inhibidores de la adn girasa; proceso de preparacion de dichos compuestos; composicion farmaceutica que los comprende; y su uso para el tratamiento de una infeccion bacteriana.
UY29183A1 (es) Formulaciones
HN2006007884A (es) Derivados de oxiindol
AR082493A1 (es) Formulaciones a base de nalbufina, y sus utilizaciones
ES2523518T3 (es) Nuevas combinaciones farmacológicas para el tratamiento de enfermedades de las vías respiratorias
EA201000039A1 (ru) Фармацевтическая композиция, включающая солифенацин или его фармацевтически приемлемую соль
CY1118132T1 (el) ΣΤΕΡΕΕΣ ΜΟΡΦΕΣ ΤΗΣ ΥΔΡΟΧΛΩΡΙΚΗΣ (1R,4R)-6'-ΦΘΟΡΟ-Ν,Ν-ΔΙΜΕΘΥΛ-4-ΦΑΙΝΥΛ-4',9'-ΔΙΥΔΡΟ-3´H-ΣΠΕΙΡΟ-[ΚΥΚΛΟΕΞΑΝΟ-1,1'-ΠΥΡΑΝΟ[3,4,b]ΙΝΔΟΛ]-4-ΑΜΙΝΗΣ
MA40698A2 (fr) Formulations pharmaceutiques d'inhibiteurs de kinase associée à la tropomyosine (trk)
ECSP088250A (es) Derivados de pirazol como agentes terapéuticos
MEP39608A (en) Novel keto-oxadiazole derivatives as cathepsin inhibitors
MX2019003317A (es) Metodo para tratar cancer usando una combinacion de agentes que dañan adn e inhibidores de proteina cinasa dependiente de adn (adn-pk).
CL2019002808A1 (es) Métodos para prevenir o tratar enfermedades oftálmicas.
CY1109018T1 (el) Φαρμακευτικη συνθεση που περιεχει ενα αλας μιρταζαπινης
ES2581331T3 (es) Inhibidor de la progresión de una enfermedad atribuida a una acumulación anormal de grasa hepática

Legal Events

Date Code Title Description
FB Suspension of granting procedure